Atlas Trials

A Precision Medicine Trial for Patients With Relapsed or Refractory T Cell ALL

Clinical trial NCT07522801 · NOT_YET_RECRUITING

Trial details

NCT number
NCT07522801
Sponsor
Philippe ROUSSELOT
Status
NOT_YET_RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
LAL
Start date
2026-09-01
Primary completion
2029-12-01
Enrollment
93

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.